Novo Nordisk A/SNYSE:NVO
- LAST PRICE115.9527
- TODAY'S CHANGE (%)-2.0573 (-1.7433%)
- Bid / Lots115.9200/ 1
- Ask / Lots115.9600/ 2
- Open / Previous Close116.6800 / 118.0100
- Day Range
- 52 Week Range
- Volume3,247,683
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVO |
|---|---|---|
| 09:32 ET | 90203 | 116.44 |
| 09:34 ET | 32288 | 116.03 |
| 09:36 ET | 46863 | 116.01 |
| 09:38 ET | 32908 | 116.38 |
| 09:39 ET | 23030 | 116.28 |
| 09:41 ET | 52547 | 116.03 |
| 09:43 ET | 34319 | 115.9229 |
| 09:45 ET | 23720 | 115.845 |
| 09:48 ET | 20498 | 115.99 |
| 09:50 ET | 15995 | 116.09 |
| 09:52 ET | 30039 | 115.99 |
| 09:54 ET | 22774 | 116.025 |
| 09:56 ET | 61022 | 116.0805 |
| 09:57 ET | 53624 | 115.92 |
| 09:59 ET | 41164 | 115.99 |
| 10:01 ET | 23543 | 115.85 |
| 10:03 ET | 25586 | 116.08 |
| 10:06 ET | 26830 | 115.86 |
| 10:08 ET | 12186 | 115.9767 |
| 10:10 ET | 37757 | 116 |
| 10:12 ET | 17523 | 116.18 |
| 10:14 ET | 24350 | 116.29 |
| 10:15 ET | 21560 | 116.25 |
| 10:17 ET | 16139 | 116.21 |
| 10:19 ET | 24785 | 116.34 |
| 10:21 ET | 31386 | 116.44 |
| 10:24 ET | 13229 | 116.42 |
| 10:26 ET | 44560 | 116.41 |
| 10:28 ET | 27289 | 116.26 |
| 10:30 ET | 30432 | 116.16 |
| 10:32 ET | 44985 | 116.1 |
| 10:33 ET | 12847 | 116.14 |
| 10:35 ET | 15452 | 116.12 |
| 10:37 ET | 12994 | 116.1399 |
| 10:39 ET | 16389 | 116.0906 |
| 10:42 ET | 13595 | 116.24 |
| 10:44 ET | 14474 | 116.3 |
| 10:46 ET | 28045 | 116.37 |
| 10:48 ET | 26786 | 116.48 |
| 10:50 ET | 28961 | 116.42 |
| 10:51 ET | 33649 | 116.51 |
| 10:53 ET | 18815 | 116.63 |
| 10:55 ET | 17406 | 116.4 |
| 10:57 ET | 47093 | 116.2 |
| 11:00 ET | 36140 | 116.01 |
| 11:02 ET | 98482 | 116.09 |
| 11:04 ET | 36465 | 116.21 |
| 11:06 ET | 22552 | 116.385 |
| 11:08 ET | 11459 | 116.29 |
| 11:09 ET | 9468 | 116.38 |
| 11:11 ET | 18943 | 116.5 |
| 11:13 ET | 13839 | 116.41 |
| 11:15 ET | 5327 | 116.435 |
| 11:18 ET | 8680 | 116.505 |
| 11:20 ET | 16488 | 116.604 |
| 11:22 ET | 43036 | 116.71 |
| 11:24 ET | 11799 | 116.5399 |
| 11:26 ET | 6243 | 116.504 |
| 11:27 ET | 12152 | 116.4 |
| 11:29 ET | 20551 | 116.295 |
| 11:31 ET | 16274 | 116.51 |
| 11:33 ET | 10639 | 116.4401 |
| 11:36 ET | 23585 | 116.42 |
| 11:38 ET | 18941 | 116.34 |
| 11:40 ET | 7108 | 116.28 |
| 11:42 ET | 9612 | 116.22 |
| 11:44 ET | 10485 | 116.2587 |
| 11:45 ET | 9784 | 116.14 |
| 11:47 ET | 9432 | 116.15 |
| 11:49 ET | 12069 | 116.195 |
| 11:51 ET | 12006 | 116.13 |
| 11:54 ET | 11615 | 116.07 |
| 11:56 ET | 38544 | 116.054 |
| 11:58 ET | 16292 | 115.915 |
| 12:00 ET | 16394 | 116 |
| 12:02 ET | 11005 | 116.01 |
| 12:03 ET | 8980 | 116.1025 |
| 12:05 ET | 12791 | 115.985 |
| 12:07 ET | 8531 | 115.98 |
| 12:09 ET | 11621 | 116.055 |
| 12:12 ET | 14657 | 116.05 |
| 12:14 ET | 6239 | 116.1002 |
| 12:16 ET | 7318 | 116.03 |
| 12:18 ET | 6076 | 116.07 |
| 12:20 ET | 10356 | 116.035 |
| 12:21 ET | 31290 | 116.1 |
| 12:23 ET | 22384 | 116.04 |
| 12:25 ET | 17424 | 116.17 |
| 12:27 ET | 12166 | 116.22 |
| 12:30 ET | 32269 | 116.25 |
| 12:32 ET | 11308 | 116.21 |
| 12:34 ET | 9152 | 116.21 |
| 12:36 ET | 13289 | 116.01 |
| 12:38 ET | 42805 | 115.9 |
| 12:39 ET | 46895 | 115.97 |
| 12:41 ET | 10174 | 116.024 |
| 12:43 ET | 4547 | 115.9471 |
| 12:45 ET | 15081 | 115.96 |
| 12:48 ET | 6907 | 116.015 |
| 12:50 ET | 15720 | 115.95 |
| 12:52 ET | 10813 | 115.97 |
| 12:54 ET | 14092 | 115.951 |
| 12:56 ET | 5134 | 115.985 |
| 12:57 ET | 2627 | 115.985 |
Today
DJ Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesDJ Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn't a Problem. -- Barrons.com, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesDJ Novo Nordisk Shares Unlikely to Move Ahead of New Drug Data -- Market Talk, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDJ Novo Nordisk's New Weight-Loss Jab Could Support Co Into 2030s -- Market Talk, from 8 hours ago by Dow Jones
8 hours ago by Dow Jones
Yesterday
DJ Novo Nordisk A/S Stock Rises Tuesday, Outperforms Market, from 12:03PM ET on Tuesday Oct 01, 2024 by Dow Jones
12:03PM ET on Tuesday Oct 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novo Nordisk A/S | 404.2B | 38.9x | +18.50% |
Catalent Inc | 10.9B | -10.5x | --- |
Royalty Pharma PLC | 16.8B | 18.8x | +1.83% |
Perrigo Company PLC | 3.5B | -30.2x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 18.9x | -3.53% |
Organon & Co | 4.8B | 4.8x | -14.04% |
Company Information
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Contact Information
- Headquarters
- Novo Alle 1BAGSVAERD, Denmark 2880
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Helge Lund
- President, Chief Executive Officer
- Lars Fruergaard Joergensen
- Vice Chairman of the Board
- Henrik Poulsen
- Chief Financial Officer, Executive Vice President
- Karsten Munk Knudsen
- Executive Vice President - International Operations
- Maziar Doustdar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $404.2B |
|---|---|
Revenue (TTM) | $38.3B |
Shares Outstanding | 3.4B |
Dividend Yield | 1.25% |
Annual Dividend Rate | 1.4462 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 08-26-24 |
Beta | 0.42 |
EPS | $2.98 |
Book Value | $3.55 |
P/E Ratio | 38.9x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 27.4x |
Operating Margin | 43.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
